Volume 7 | Issue -2
Volume 7 | Issue -2
Volume 7 | Issue -2
Volume 7 | Issue -2
Volume 7 | Issue -2
Coronavirus disease (COVID-19) is caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-Cov-2) and was declared a pandemic by WHO in 2020. When the human body is infected with a virus, it will respond by forming antibodies such as IgM and IgG. In forming antibodies, the body will show clinical manifestations that can be grouped according to degree. The degree of clinical manifestations in the course of the disease affects the antibody response produced, so this study aims to determine the relationship between clinical manifestations and the level of IgG Anti-SARS-Cov-2 antibodies in COVID-19 patients confirmed to have recovered in Bengkulu City in 2020.